Efficacy Study of Blinatumomab Clean Up Early Residual Disease for Newly Diagnosed Pediatric B Lymphoblastic Leukemia
Clinical trial NCT06607419 · RECRUITING
Trial details
- NCT number
- NCT06607419
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-21
- Primary completion
- 2025-05-31
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.